E
Pulmonx Corporation
LUNG
$7.32
$0.020.27%
E
Sell
2/26/2025Downgrade
Pulmonx Corporation (LUNG) was downgraded to E+ from D- on 2/26/2025 due to a decline in the valuation index.
Pulmonx Corporation (LUNG) was downgraded to E+ from D- on 2/26/2025 due to a decline in the valuation index.
D
Sell
2/7/2025Upgraded
Pulmonx Corporation (LUNG) was upgraded to D- from E+ on 2/7/2025 due to an increase in the volatility index, total return index and growth index.
Pulmonx Corporation (LUNG) was upgraded to D- from E+ on 2/7/2025 due to an increase in the volatility index, total return index and growth index.
E
Sell
1/23/2025Downgrade
Pulmonx Corporation (LUNG) was downgraded to E+ from D- on 1/23/2025 due to a decline in the volatility index and total return index.
Pulmonx Corporation (LUNG) was downgraded to E+ from D- on 1/23/2025 due to a decline in the volatility index and total return index.
D
Sell
11/4/2024Upgraded
Pulmonx Corporation (LUNG) was upgraded to D- from E+ on 11/4/2024 due to an increase in the volatility index.
Pulmonx Corporation (LUNG) was upgraded to D- from E+ on 11/4/2024 due to an increase in the volatility index.
E
Sell
10/17/2024Downgrade
Pulmonx Corporation (LUNG) was downgraded to E+ from D- on 10/17/2024 due to a decline in the volatility index.
Pulmonx Corporation (LUNG) was downgraded to E+ from D- on 10/17/2024 due to a decline in the volatility index.
D
Sell
9/27/2024Upgraded
Pulmonx Corporation (LUNG) was upgraded to D- from E+ on 9/27/2024 due to an increase in the volatility index and total return index.
Pulmonx Corporation (LUNG) was upgraded to D- from E+ on 9/27/2024 due to an increase in the volatility index and total return index.
E
Sell
9/12/2024Downgrade
Pulmonx Corporation (LUNG) was downgraded to E+ from D- on 9/12/2024 due to a decline in the volatility index and valuation index.
Pulmonx Corporation (LUNG) was downgraded to E+ from D- on 9/12/2024 due to a decline in the volatility index and valuation index.
D
Sell
8/22/2024Upgraded
Pulmonx Corporation (LUNG) was upgraded to D- from E+ on 8/22/2024 due to an increase in the volatility index and valuation index.
Pulmonx Corporation (LUNG) was upgraded to D- from E+ on 8/22/2024 due to an increase in the volatility index and valuation index.
E
Sell
8/7/2024Downgrade
Pulmonx Corporation (LUNG) was downgraded to E+ from D- on 8/7/2024 due to a decline in the volatility index and solvency index. Debt to equity increased from 0.36 to 0.38.
Pulmonx Corporation (LUNG) was downgraded to E+ from D- on 8/7/2024 due to a decline in the volatility index and solvency index. Debt to equity increased from 0.36 to 0.38.
D
Sell
7/18/2024Upgraded
Pulmonx Corporation (LUNG) was upgraded to D- from E+ on 7/18/2024 due to an increase in the volatility index.
Pulmonx Corporation (LUNG) was upgraded to D- from E+ on 7/18/2024 due to an increase in the volatility index.
E
Sell
7/2/2024Downgrade
Pulmonx Corporation (LUNG) was downgraded to E+ from D- on 7/2/2024 due to a decline in the volatility index and total return index.
Pulmonx Corporation (LUNG) was downgraded to E+ from D- on 7/2/2024 due to a decline in the volatility index and total return index.
D
Sell
6/11/2024Upgraded
Pulmonx Corporation (LUNG) was upgraded to D- from E+ on 6/11/2024 due to an increase in the volatility index and valuation index.
Pulmonx Corporation (LUNG) was upgraded to D- from E+ on 6/11/2024 due to an increase in the volatility index and valuation index.
E
Sell
5/24/2024Downgrade
Pulmonx Corporation (LUNG) was downgraded to E+ from D- on 5/24/2024 due to a decline in the volatility index, total return index and valuation index.
Pulmonx Corporation (LUNG) was downgraded to E+ from D- on 5/24/2024 due to a decline in the volatility index, total return index and valuation index.
D
Sell
5/7/2024Upgraded
Pulmonx Corporation (LUNG) was upgraded to D- from E+ on 5/7/2024 due to an increase in the volatility index and solvency index. The quick ratio increased from 5.62 to 5.98.
Pulmonx Corporation (LUNG) was upgraded to D- from E+ on 5/7/2024 due to an increase in the volatility index and solvency index. The quick ratio increased from 5.62 to 5.98.
E
Sell
5/3/2024Downgrade
Pulmonx Corporation (LUNG) was downgraded to E+ from D- on 5/3/2024 due to a decline in the total return index, volatility index and growth index.
Pulmonx Corporation (LUNG) was downgraded to E+ from D- on 5/3/2024 due to a decline in the total return index, volatility index and growth index.
D
Sell
4/11/2024Upgraded
Pulmonx Corporation (LUNG) was upgraded to D- from E+ on 4/11/2024 due to an increase in the volatility index and valuation index.
Pulmonx Corporation (LUNG) was upgraded to D- from E+ on 4/11/2024 due to an increase in the volatility index and valuation index.
E
Sell
3/21/2024Downgrade
Pulmonx Corporation (LUNG) was downgraded to E+ from D- on 3/21/2024 due to a decline in the volatility index.
Pulmonx Corporation (LUNG) was downgraded to E+ from D- on 3/21/2024 due to a decline in the volatility index.
D
Sell
3/6/2024Upgraded
Pulmonx Corporation (LUNG) was upgraded to D- from E+ on 3/6/2024 due to an increase in the total return index, growth index and volatility index. Total revenue increased 9.11% from $17.67M to $19.28M, EBIT increased 8.28% from -$15.18M to -$13.92M, and earnings per share increased from -$0.3909 to -$0.3619.
Pulmonx Corporation (LUNG) was upgraded to D- from E+ on 3/6/2024 due to an increase in the total return index, growth index and volatility index. Total revenue increased 9.11% from $17.67M to $19.28M, EBIT increased 8.28% from -$15.18M to -$13.92M, and earnings per share increased from -$0.3909 to -$0.3619.
E
Sell
11/9/2023Downgrade
Pulmonx Corporation (LUNG) was downgraded to E+ from D- on 11/9/2023 due to a decline in the volatility index, solvency index and total return index. The quick ratio declined from 7.43 to 6.22, and debt to equity increased from 0.3 to 0.32.
Pulmonx Corporation (LUNG) was downgraded to E+ from D- on 11/9/2023 due to a decline in the volatility index, solvency index and total return index. The quick ratio declined from 7.43 to 6.22, and debt to equity increased from 0.3 to 0.32.
D
Sell
10/27/2023Upgraded
Pulmonx Corporation (LUNG) was upgraded to D- from E+ on 10/27/2023 due to an increase in the volatility index and valuation index.
Pulmonx Corporation (LUNG) was upgraded to D- from E+ on 10/27/2023 due to an increase in the volatility index and valuation index.
E
Sell
10/12/2023Downgrade
Pulmonx Corporation (LUNG) was downgraded to E+ from D- on 10/12/2023 due to a decline in the volatility index and total return index.
Pulmonx Corporation (LUNG) was downgraded to E+ from D- on 10/12/2023 due to a decline in the volatility index and total return index.
D
Sell
9/22/2023Upgraded
Pulmonx Corporation (LUNG) was upgraded to D- from E+ on 9/22/2023 due to an increase in the volatility index and total return index.
Pulmonx Corporation (LUNG) was upgraded to D- from E+ on 9/22/2023 due to an increase in the volatility index and total return index.
E
Sell
9/7/2023Downgrade
Pulmonx Corporation (LUNG) was downgraded to E+ from D- on 9/7/2023 due to a decline in the volatility index.
Pulmonx Corporation (LUNG) was downgraded to E+ from D- on 9/7/2023 due to a decline in the volatility index.
D
Sell
8/17/2023Upgraded
Pulmonx Corporation (LUNG) was upgraded to D- from E+ on 8/17/2023 due to an increase in the growth index, solvency index and total return index. Operating cash flow increased 37.59% from -$12.64M to -$7.89M, and total revenue increased 18.29% from $14.54M to $17.19M.
Pulmonx Corporation (LUNG) was upgraded to D- from E+ on 8/17/2023 due to an increase in the growth index, solvency index and total return index. Operating cash flow increased 37.59% from -$12.64M to -$7.89M, and total revenue increased 18.29% from $14.54M to $17.19M.
E
Sell
6/14/2023Downgrade
Pulmonx Corporation (LUNG) was downgraded to E+ from D- on 6/14/2023 due to a decline in the valuation index.
Pulmonx Corporation (LUNG) was downgraded to E+ from D- on 6/14/2023 due to a decline in the valuation index.
D
Sell
5/30/2023Upgraded
Pulmonx Corporation (LUNG) was upgraded to D- from E+ on 5/30/2023 due to an increase in the volatility index and total return index.
Pulmonx Corporation (LUNG) was upgraded to D- from E+ on 5/30/2023 due to an increase in the volatility index and total return index.
E
Sell
5/5/2023Downgrade
Pulmonx Corporation (LUNG) was downgraded to E+ from D- on 5/5/2023 due to a decline in the volatility index, growth index and valuation index.
Pulmonx Corporation (LUNG) was downgraded to E+ from D- on 5/5/2023 due to a decline in the volatility index, growth index and valuation index.
D
Sell
4/17/2023Upgraded
Pulmonx Corporation (LUNG) was upgraded to D- from E+ on 4/17/2023 due to an increase in the total return index and volatility index.
Pulmonx Corporation (LUNG) was upgraded to D- from E+ on 4/17/2023 due to an increase in the total return index and volatility index.
E
Sell
3/14/2023Downgrade
Pulmonx Corporation (LUNG) was downgraded to E+ from D on 3/14/2023 due to a noticeable decline in the solvency index, growth index and valuation index. EBIT declined 5% from -$13.93M to -$14.63M, and earnings per share declined from -$0.3811 to -$0.3821.
Pulmonx Corporation (LUNG) was downgraded to E+ from D on 3/14/2023 due to a noticeable decline in the solvency index, growth index and valuation index. EBIT declined 5% from -$13.93M to -$14.63M, and earnings per share declined from -$0.3811 to -$0.3821.
D
Sell
2/9/2023Upgraded
Pulmonx Corporation (LUNG) was upgraded to D from E+ on 2/9/2023 due to an increase in the volatility index.
Pulmonx Corporation (LUNG) was upgraded to D from E+ on 2/9/2023 due to an increase in the volatility index.
E
Sell
2/8/2023Downgrade
Pulmonx Corporation (LUNG) was downgraded to E+ from D on 2/8/2023 due to a decline in the total return index, volatility index and valuation index.
Pulmonx Corporation (LUNG) was downgraded to E+ from D on 2/8/2023 due to a decline in the total return index, volatility index and valuation index.
D
Sell
12/27/2022Upgraded
Pulmonx Corporation (LUNG) was upgraded to D from D- on 12/27/2022 due to an increase in the volatility index and total return index.
Pulmonx Corporation (LUNG) was upgraded to D from D- on 12/27/2022 due to an increase in the volatility index and total return index.
D
Sell
12/9/2022Downgrade
Pulmonx Corporation (LUNG) was downgraded to D- from D on 12/9/2022 due to a decline in the volatility index, total return index and solvency index. The quick ratio declined from 8.3 to 7.59, and debt to equity increased from 0.12 to 0.13.
Pulmonx Corporation (LUNG) was downgraded to D- from D on 12/9/2022 due to a decline in the volatility index, total return index and solvency index. The quick ratio declined from 8.3 to 7.59, and debt to equity increased from 0.12 to 0.13.
D
Sell
5/16/2022Upgraded
Pulmonx Corporation (LUNG) was upgraded to D from E+ on 5/16/2022 due to an increase in the valuation index.
Pulmonx Corporation (LUNG) was upgraded to D from E+ on 5/16/2022 due to an increase in the valuation index.
E
Sell
5/13/2022Downgrade
Pulmonx Corporation (LUNG) was downgraded to E+ from D on 5/13/2022 due to a decline in the total return index, volatility index and solvency index. Debt to equity increased from 0.1 to 0.11, and the quick ratio declined from 10.65 to 10.
Pulmonx Corporation (LUNG) was downgraded to E+ from D on 5/13/2022 due to a decline in the total return index, volatility index and solvency index. Debt to equity increased from 0.1 to 0.11, and the quick ratio declined from 10.65 to 10.
D
Sell
5/4/2022Upgraded
Pulmonx Corporation (LUNG) was upgraded to D from E+ on 5/4/2022 due to an increase in the valuation index and total return index.
Pulmonx Corporation (LUNG) was upgraded to D from E+ on 5/4/2022 due to an increase in the valuation index and total return index.
E
Sell
5/1/2022Downgrade
Pulmonx Corporation (LUNG) was downgraded to E+ from D on 5/1/2022 due to a decline in the total return index.
Pulmonx Corporation (LUNG) was downgraded to E+ from D on 5/1/2022 due to a decline in the total return index.
D
Sell
4/21/2022Upgraded
Pulmonx Corporation (LUNG) was upgraded to D from E+ on 04/21/2022.
Pulmonx Corporation (LUNG) was upgraded to D from E+ on 04/21/2022.
E
Sell
4/20/2022Downgrade
Pulmonx Corporation (LUNG) was downgraded to E+ from D on 4/20/2022 due to a decline in the total return index, solvency index and volatility index.
Pulmonx Corporation (LUNG) was downgraded to E+ from D on 4/20/2022 due to a decline in the total return index, solvency index and volatility index.
D
Sell
11/9/2021Upgraded
Pulmonx Corporation (LUNG) was upgraded to D from E+ on 11/9/2021 due to an increase in the total return index.
Pulmonx Corporation (LUNG) was upgraded to D from E+ on 11/9/2021 due to an increase in the total return index.
E
Sell
11/8/2021Downgrade
Pulmonx Corporation (LUNG) was downgraded to E+ from D on 11/8/2021 due to a significant decline in the volatility index, total return index and valuation index.
Pulmonx Corporation (LUNG) was downgraded to E+ from D on 11/8/2021 due to a significant decline in the volatility index, total return index and valuation index.
D
Sell
3/17/2021Downgrade
Pulmonx Corporation (LUNG) was downgraded to D from D+ on 3/17/2021 due to a major decline in the growth index, efficiency index and volatility index. Net income declined 140.85% from -$3.86M to -$9.3M, EBIT declined 74.91% from -$5.35M to -$9.35M, and operating cash flow declined 24.58% from -$5.83M to -$7.26M.
Pulmonx Corporation (LUNG) was downgraded to D from D+ on 3/17/2021 due to a major decline in the growth index, efficiency index and volatility index. Net income declined 140.85% from -$3.86M to -$9.3M, EBIT declined 74.91% from -$5.35M to -$9.35M, and operating cash flow declined 24.58% from -$5.83M to -$7.26M.
D
Sell
12/24/2020None
Pulmonx Corporation (LUNG) was downgraded to D+ from U on 12/24/2020.
Pulmonx Corporation (LUNG) was downgraded to D+ from U on 12/24/2020.
NASDAQ
03/12/2025 4:00PM Eastern
Quotes delayed
